EGM
SNDX icon

Engineers Gate Manager’s Syndax Pharmaceuticals SNDX Stock Holding History

Engineers Gate Manager’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468K Sell
21,401
-17,007
-44% -$354K 0.01% 1560
2026
Q1 		$897K Buy
38,408
+12,143
+46% +$264K 0.01% 1105
2025
Q4 		$552K Sell
26,265
-153,101
-85% -$2.67M 0.01% 1309
2025
Q3 		$2.76M Buy
179,366
+90
+0.1% +$1.18K 0.03% 610
2025
Q2 		$1.68M Buy
179,276
+52,791
+42% +$581K 0.02% 829
2025
Q1 		$1.55M Sell
126,485
-21,188
-14% -$299K 0.03% 815
2024
Q4 		$1.95M Buy
147,673
+88,262
+149% +$1.51M 0.03% 638
2024
Q3 		$1.14M Sell
59,411
-16,429
-22% -$339K 0.02% 909
2024
Q2 		$1.56M Buy
75,840
+33,353
+79% +$698K 0.04% 680
2024
Q1 		$1.01M Buy
42,487
+26,247
+162% +$585K 0.03% 819
2023
Q4 		$351K Sell
16,240
-54,296
-77% -$835K 0.01% 1367
2023
Q3 		$1.02M Buy
70,536
+9,793
+16% +$185K 0.04% 695
2023
Q2 		$1.27M Buy
60,743
+9,318
+18% +$194K 0.05% 551
2023
Q1 		$1.09M Buy
+51,425
New +$1.28M 0.05% 581
2022
Q2 		– Sell
-40,804
Closed -$709K – 2235
2022
Q1 		$709K Buy
40,804
+17,506
+75% +$295K 0.03% 875
2021
Q4 		$510K Buy
+23,298
New +$430K 0.02% 1042
2021
Q3 		– Sell
-16,609
Closed -$285K – 1952
2021
Q2 		$285K Sell
16,609
-6,759
-29% -$124K 0.02% 1171
2021
Q1 		$523K Buy
23,368
+5,552
+31% +$125K 0.03% 967
2020
Q4 		$396K Buy
+17,816
New +$369K 0.02% 1126

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Engineers Gate Manager's SNDX Position: Q2 2026 in Review

Engineers Gate Manager reduced its Syndax Pharmaceuticals (SNDX) stake by 44% in Q2 2026, selling an estimated $354K and leaving 21,401 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #1560.

Engineers Gate Manager first reported a position in SNDX in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.76M in Q3 2025. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Engineers Gate Manager held 21,401 shares of Syndax Pharmaceuticals worth $468K as of Q2 2026.
  • Engineers Gate Manager sold 17,007 Syndax Pharmaceuticals shares in Q2 2026, an estimated $354K.
  • Syndax Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1560 holding.
  • Engineers Gate Manager first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • Engineers Gate Manager's Syndax Pharmaceuticals position peaked at $2.76M in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.